Is ESSA Pharma Inc. (EPIX) a Buy, Sell, or Hold?
ESSA Pharma Inc.
NASDAQ:EPIX
$0.2012 USD
$0.0 (-1.85%)
- Volume
- 5.95M
- Average Volume
- 6.75M
- Market Capitalization
- $9.52M
- P/E Ratio
- -0.87
- Dividend Yield
- 0.00%
- Price Target
- $9.50
- Year High
- $6.45
- Year Low
- $0.18
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $69.07
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
4
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
13
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 8.09M
EPIX Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
EPIX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Parkinson David Ross | director, officer: President and CEO | 2025-10-09 | D-Return | 0.12 | 2025-10-15 |
| Wood David S. | officer: Chief Financial Officer | 2025-10-09 | D-Return | 0.12 | 2025-10-15 |
| BERGER FRANKLIN M | director | 2025-10-09 | D-Return | 0.12 | 2025-10-15 |
| Glickman Richard M | director | 2025-10-09 | D-Return | 0.12 | 2025-10-15 |
| Requadt Scott | director | 2025-10-09 | D-Return | 0.12 | 2025-10-15 |
| Martin John Alexander | director | 2025-10-09 | D-Return | 0.12 | 2025-10-15 |
| Thorell Marella | director | 2025-10-09 | D-Return | 0.12 | 2025-10-15 |
| BVF PARTNERS L P/IL | 10 percent owner | 2025-10-09 | U-Tender | 0.124231 | 2025-10-14 |
| BVF PARTNERS L P/IL | 10 percent owner | 2025-08-05 | X-InTheMoney | 0.0001 | 2025-08-07 |
| BVF PARTNERS L P/IL | 10 percent owner | 2025-08-05 | S-Sale | 1.8779 | 2025-08-07 |
| BVF PARTNERS L P/IL | 10 percent owner | 2025-08-05 | X-InTheMoney | 0.0001 | 2025-08-07 |
| BVF PARTNERS L P/IL | 10 percent owner | 2025-08-05 | S-Sale | 1.8779 | 2025-08-07 |
| BVF PARTNERS L P/IL | 10 percent owner | 2025-08-05 | X-InTheMoney | 0.0001 | 2025-08-07 |
| BVF PARTNERS L P/IL | 10 percent owner | 2025-08-05 | S-Sale | 1.8779 | 2025-08-07 |
| BVF PARTNERS L P/IL | 10 percent owner | 2025-08-05 | X-InTheMoney | 0.0001 | 2025-08-07 |
| BIOTECH GROWTH N V | 10 percent owner | 2024-11-01 | S-Sale | 1.532 | 2024-11-05 |
| BIOTECH GROWTH N V | 10 percent owner | 2024-11-01 | S-Sale | 1.5259 | 2024-11-05 |
| BIOTECH GROWTH N V | 10 percent owner | 2024-11-01 | S-Sale | 1.5294 | 2024-11-05 |
| BIOTECH GROWTH N V | 10 percent owner | 2024-11-01 | S-Sale | 1.513 | 2024-11-05 |
| Virsik Peter | officer: Chief Operating Officer | 2024-09-09 | S-Sale | 6 | 2024-09-09 |
| Virsik Peter | officer: Chief Operating Officer | 2024-09-03 | S-Sale | 6.03 | 2024-09-03 |
| Virsik Peter | officer: Chief Operating Officer | 2024-05-06 | S-Sale | 6.95 | 2024-05-06 |
| Glickman Richard M | director | 2024-04-24 | M-Exempt | 4.9 | 2024-04-25 |
| Glickman Richard M | director | 2024-04-24 | M-Exempt | 4.9 | 2024-04-25 |
| Virsik Peter | officer: Chief Operating Officer | 2024-04-05 | S-Sale | 7.94 | 2024-04-05 |
| ZWEIFACH SANFORD S | director | 2024-03-25 | A-Award | 9.04 | 2024-03-28 |
| Thorell Marella | director | 2024-03-25 | A-Award | 9.04 | 2024-03-28 |
| Sollis Gary | director | 2024-03-25 | A-Award | 9.04 | 2024-03-28 |
| Requadt Scott | director | 2024-03-25 | A-Award | 9.04 | 2024-03-28 |
| Merendino Lauren | director | 2024-03-25 | A-Award | 9.04 | 2024-03-28 |
| Martin John Alexander | director | 2024-03-25 | A-Award | 9.04 | 2024-03-28 |
| Kantoff Philip W. | director | 2024-03-25 | A-Award | 9.04 | 2024-03-28 |
| Glickman Richard M | director | 2024-03-25 | A-Award | 9.04 | 2024-03-28 |
| BERGER FRANKLIN M | director | 2024-03-25 | A-Award | 9.04 | 2024-03-28 |
| Wood David S. | officer: Chief Financial Officer | 2024-03-25 | A-Award | 9.04 | 2024-03-28 |
| Virsik Peter | officer: Chief Operating Officer | 2024-03-25 | A-Award | 9.04 | 2024-03-28 |
| Parkinson David Ross | director, officer: Chief Executive Officer | 2024-03-25 | A-Award | 9.04 | 2024-03-28 |
| Cesano Alessandra | officer: Chief Medical Officer | 2024-03-25 | A-Award | 9.04 | 2024-03-28 |
| Virsik Peter | officer: Chief Operating Officer | 2024-03-05 | S-Sale | 8.98 | 2024-03-05 |
| Virsik Peter | officer: Chief Operating Officer | 2024-02-06 | M-Exempt | 3.23 | 2024-02-07 |
| Virsik Peter | officer: Chief Operating Officer | 2024-02-06 | M-Exempt | 3.23 | 2024-02-07 |
| Virsik Peter | officer: Chief Operating Officer | 2024-02-06 | S-Sale | 10.29 | 2024-02-07 |
| Virsik Peter | officer: Chief Operating Officer | 2024-02-05 | M-Exempt | 3.23 | 2024-02-06 |
| Virsik Peter | officer: Chief Operating Officer | 2024-02-05 | M-Exempt | 3.23 | 2024-02-06 |
| Virsik Peter | officer: Chief Operating Officer | 2024-02-05 | S-Sale | 9.25 | 2024-02-06 |
| Virsik Peter | officer: Chief Operating Officer | 2024-02-05 | S-Sale | 10.04 | 2024-02-06 |
| Virsik Peter | officer: Chief Operating Officer | 2024-01-16 | M-Exempt | 3.23 | 2024-01-17 |
| Virsik Peter | officer: Chief Operating Officer | 2024-01-16 | M-Exempt | 3.23 | 2024-01-17 |
| Virsik Peter | officer: Chief Operating Officer | 2024-01-16 | S-Sale | 10.01 | 2024-01-17 |
| Requadt Scott | director | 2023-10-30 | J-Other | 0 | 2024-01-16 |
| Requadt Scott | director | 2023-11-06 | J-Other | 0 | 2024-01-16 |
| Virsik Peter | officer: Chief Operating Officer | 2024-01-05 | S-Sale | 6.11 | 2024-01-08 |
| Parkinson David Ross | director, officer: Chief Executive Officer | 2023-12-14 | P-Purchase | 2.3 | 2023-12-18 |
| Wood David S. | officer: Chief Financial Officer | 2023-10-24 | A-Award | 3.91 | 2023-11-24 |
| BERGER FRANKLIN M | director | 2023-11-21 | P-Purchase | 5.73 | 2023-11-22 |
| BERGER FRANKLIN M | director | 2023-11-03 | P-Purchase | 5.99 | 2023-11-16 |
| BERGER FRANKLIN M | director | 2023-11-02 | P-Purchase | 5.35 | 2023-11-16 |
| Merendino Lauren | director | 2023-06-06 | 3.05 | 2023-06-06 | |
| Parkinson David Ross | officer: Chief Executive Officer | 2022-12-30 | P-Purchase | 2.6 | 2023-01-05 |
| Parkinson David Ross | officer: Chief Executive Officer | 2022-12-22 | P-Purchase | 2.39 | 2023-01-05 |
| BERGER FRANKLIN M | director | 2022-12-14 | S-Sale | 3 | 2023-01-05 |
| BERGER FRANKLIN M | director | 2022-12-15 | S-Sale | 2.9 | 2023-01-05 |
| BERGER FRANKLIN M | director | 2022-12-15 | S-Sale | 2.86 | 2023-01-05 |
| BERGER FRANKLIN M | director | 2022-12-16 | S-Sale | 2.67 | 2023-01-05 |
| BERGER FRANKLIN M | director | 2022-12-20 | S-Sale | 2.53 | 2023-01-05 |
| BERGER FRANKLIN M | director | 2022-12-21 | S-Sale | 2.41 | 2023-01-05 |
| BERGER FRANKLIN M | director | 2022-12-21 | S-Sale | 2.42 | 2023-01-05 |
| Wood David S. | officer: Chief Financial Officer | 2022-12-30 | P-Purchase | 2.6 | 2023-01-05 |
| ZWEIFACH SANFORD S | director | 2022-06-29 | A-Award | 0 | 2022-11-01 |
| Wood David S. | officer: Chief Financial Officer | 2022-06-29 | A-Award | 0 | 2022-11-01 |
| Virsik Peter | officer: Chief Operating Officer | 2022-06-29 | A-Award | 0 | 2022-11-01 |
| Thorell Marella | director | 2022-06-29 | A-Award | 0 | 2022-11-01 |
| Sollis Gary | director | 2022-06-29 | A-Award | 0 | 2022-11-01 |
| Requadt Scott | director | 2022-06-29 | A-Award | 0 | 2022-11-01 |
| Parkinson David Ross | officer: Chief Executive Officer | 2022-06-29 | A-Award | 0 | 2022-11-01 |
| Martin John Alexander | director | 2022-06-29 | A-Award | 0 | 2022-11-01 |
| Glickman Richard M | director | 2022-06-29 | A-Award | 0 | 2022-11-01 |
| Cesano Alessandra | officer: Chief Medical Officer | 2022-06-29 | A-Award | 0 | 2022-11-01 |
| BERGER FRANKLIN M | director | 2022-06-29 | A-Award | 0 | 2022-11-01 |
| BIOTECH GROWTH N V | director | 2022-10-27 | P-Purchase | 4.5022 | 2022-10-28 |
| BIOTECH GROWTH N V | director | 2022-10-26 | P-Purchase | 3.979 | 2022-10-28 |
| BVF PARTNERS L P/IL | 10 percent owner | 2022-07-11 | 0 | 2022-07-21 | |
| BVF PARTNERS L P/IL | 10 percent owner | 2022-07-11 | 0 | 2022-07-21 | |
| BVF PARTNERS L P/IL | 10 percent owner | 2022-07-11 | 0 | 2022-07-21 | |
| BVF PARTNERS L P/IL | 10 percent owner | 2022-07-11 | 0.0001 | 2022-07-21 | |
| BB BIOTECH AG | director: | 2022-07-18 | P-Purchase | 3.1558 | 2022-07-20 |
| BIOTECH GROWTH N V | 10 percent owner | 2022-07-18 | P-Purchase | 3.1558 | 2022-07-20 |
| BIOTECH GROWTH N V | 10 percent owner | 2022-07-15 | P-Purchase | 3.1316 | 2022-07-18 |
| BIOTECH GROWTH N V | 10 percent owner | 2022-07-14 | P-Purchase | 2.7921 | 2022-07-18 |
| BB BIOTECH AG | director: | 2022-07-14 | P-Purchase | 2.7921 | 2022-07-18 |
| Parkinson David Ross | officer: Chief Executive Officer | 2022-06-30 | P-Purchase | 2.958 | 2022-07-05 |
| BIOTECH GROWTH N V | 10 percent owner | 2022-04-27 | S-Sale | 5.8536 | 2022-04-28 |
| BB BIOTECH AG | director: | 2022-04-27 | S-Sale | 5.8536 | 2022-04-28 |
| BIOTECH GROWTH N V | 10 percent owner | 2021-08-18 | P-Purchase | 8.8752 | 2021-08-20 |
| BIOTECH GROWTH N V | 10 percent owner | 2021-08-16 | 0 | 2021-08-17 | |
| BERGER FRANKLIN M | director | 2021-02-22 | P-Purchase | 27 | 2021-03-04 |
| ZWEIFACH SANFORD S | director | 2020-12-11 | A-Award | 7 | 2021-01-26 |
| Sollis Gary | director | 2020-12-11 | A-Award | 7 | 2021-01-26 |
| Glickman Richard M | director | 2020-12-11 | A-Award | 7 | 2021-01-26 |
| Brettman Ari David | director | 2020-12-11 | A-Award | 7 | 2021-01-26 |